US2011239317A1PendingUtilityA1
Polynucleotides encoding promyostatin polypeptides
Est. expiryFeb 5, 2017(expired)· nominal 20-yr term from priority
A61P 21/00C07K 5/1019C07K 14/475A61K 38/00
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides isolated polynucleotides encoding promyostatin polypeptides or a peptide portion thereof, polynucleotides complementary thereto, and oligonucleotides that can specifically hybridize to such polynucleotides. The present invention also provides an isolated polynucleotide encoding a mature myostatin peptide.
Claims
exact text as granted — not AI-modified1 . A transgenic non-human animal comprising a transgene encoding a truncated or mutated growth differentiation factor-8 (GDF-8) gene, wherein the transgene undergoes homologous recombination with an endogenous GDF-8 gene within the genome, thereby resulting in truncation of the endogenous GDF-8 gene, wherein the truncated endogenous GDF-8 gene lacks GDF-8 activity, and wherein the transgenic animal has increased muscle mass as compared to a wildtype animal.
2 . The transgenic animal of claim 1 , where the animal is a species of avian, bovine, porcine, ovine, or piscine.
3 . The transgenic animal of claim 1 , wherein the animal is homozygous or heterozygous for GDF-8 polynucleotide.
4 . A chicken or turkey egg produced by the transgenic avian species of claim 2 .
5 . Beef obtained from the transgenic bovine of claim 2 .
6 . Milk obtained from the transgenic bovine or transgenic ovine of claim 2 .
7 . Pork obtained from the transgenic porcine of claim 2 .
8 . Lamb obtained from the transgenic ovine of claim 2 .
9 . Chicken or turkey meat produced by the transgenic avian species of claim 2 .
10 . A method of producing animal food products having increased muscle mass comprising:
a) introducing a transgene by homologous targeting into a pronuclear embryo or embryonic stem cells of the animal comprising a polynucleotide encoding a growth differentiation factor-8 (GDF-8) polypeptide, wherein the transgene comprises an exogenous polynucleotide encoding a truncated or mutated GDF-8 polypeptide; b) implanting the embryo or embryonic stem cells into the oviduct of a pseudopregnant female of the same species, thereby allowing the embryo or embryonic stem cells to mature to full term progeny; c) cross-breeding transgene-positive progeny expressing the truncated or mutated GDF-8 polypeptide with each other to obtain further transgene-positive progeny, whereby the progeny have increased muscle mass and wherein the food products and the progeny include somatic and germ cells with the transgene; and d) processing the transgene-positive progeny to obtain food products.Join the waitlist — get patent alerts
Track US2011239317A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.